BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/76/0.1/20.12.24 | Market Closed - Boerse Frankfurt Warrants 13:52:19 2024-06-27 EDT | ||
| 0.145 EUR | -12.65% |
|
| Current month | -46.30% | ||
| 1 month | -36.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 0.145 | -12.65% |
| 24-06-26 | 0.166 | -8.29% |
| 24-06-25 | 0.181 | +4.02% |
| 24-06-24 | 0.174 | -10.31% |
| 24-06-21 | 0.194 | -5.83% |
Real-time Boerse Frankfurt Warrants
Last update June 27, 2024 at 01:52 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD3R89 |
| ISIN | DE000VD3R892 |
| Date issued | 2024-04-09 |
| Strike | 76 $ |
| Maturity | 2024-12-20 (176 Days) |
| Parity | 10 : 1 |
| Emission price | 0.26 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.4 € |
|---|---|
| Lowest since issue | 0.145 € |
| Delta | -0.05x |
| Omega | 4.436 |
| Premium | 46.63x |
| Gearing | 86.81x |
| Moneyness | 0.5452 |
| Difference Strike | -17.34 $ |
| Difference Strike % | -22.82% |
| Spread | 0.01 € |
| Spread % | 6.45% |
| Theoretical value | 0.1500 |
| Implied Volatility | 64.62 % |
| Total Loss Probability | 88.21 % |
| Intrinsic value | 0.000000 |
| Present value | 0.1500 |
| Break even | 74.39 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | -0x |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
93.34
USD
Average target price
96.05
USD
Spread / Average Target
+2.91%
- Stock Market
- Warrants
- Warrant
